Alto Ingredients, Inc.
NASDAQ:ALTOChemicals - Specialty
-$0.07 today
- Market cap
- $257.92M
- Beta
- 0.14
- P/E (TTM)
- 12.5
- EPS (TTM)
- $0.39
Volume 1.03M
Average 1.92M
ALTO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Alto Ingredients, Inc.NASDAQ: ALTO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How ALTO compares with its peers on the latest reported figures
- ALTO's LTM Mar 2026 research & development of $0 is the 4th highest of the 7 companies compared; the peer median is $1.66M.
- Research & development amounts to 0.0% of revenue for ALTO, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $70M | -6.7% | +2.5% | 1.4% | |
| LTM Mar 2026 | $10.63M | +195.4% | -36.2% | 6.1% | |
| LTM Mar 2026 | $3.32M | -26.0% | +4.2% | 3.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Apr 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ALTO) | $1.66M | -16.3% | +2.5% | 0.7% | |
Competitors are the stored peer set for ALTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.21B | 1.34B | 1.22B | 965.26M | 917.93M |
| Cost of Revenue | 1.14B | 1.36B | 1.21B | 955.54M | 891.08M |
| Gross Profit | 67.78M | (27.55M) | 15.65M | 9.72M | 26.85M |
| Gross Margin | 5.6% | -2.1% | 1.3% | 1.0% | 2.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 29.19M | 28.08M | 32.66M | 29.74M | 27.21M |
| Operating Expenses | 27.71M | 33.81M | 39.5M | 61.4M | 19.71M |
| Depreciation & Amortization | 23.29M | 25.1M | 23.08M | 24.41M | 25.22M |
| EBITDA | 74.43M | (12.75M) | 2.6M | (26.76M) | 48.7M |
| EBITDA Margin | 6.2% | -1.0% | 0.2% | -2.8% | 5.3% |
| Operating Income | 40.07M | (61.36M) | (23.85M) | (51.68M) | 7.14M |
| Operating Margin | 3.3% | -4.6% | -2.0% | -5.4% | 0.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.59M | 1.83M | 7.43M | 7.64M | 10.77M |
| Other Income / Expenses | 7.48M | 21.69M | (4.06M) | (7.14M) | 5.58M |
| Income Before Tax | 47.55M | (39.67M) | (27.91M) | (58.81M) | 12.72M |
| Pre-Tax Margin | 3.9% | -3.0% | -2.3% | -6.1% | 1.4% |
| Income Tax Expense | 1.47M | 1.93M | 97K | 173K | (621K) |
| Net Income | 46.08M | (41.6M) | (28.01M) | (58.98M) | 13.34M |
| Net Margin | 3.8% | -3.1% | -2.3% | -6.1% | 1.5% |
| EPS (Basic) | 0.62 | (0.58) | (0.40) | (0.82) | 0.16 |
| EPS (Diluted) | 0.61 | (0.58) | (0.40) | (0.82) | 0.16 |
| Weighted Avg Shares | 71.1M | 71.94M | 73.34M | 73.48M | 74.51M |
| Weighted Avg Shares (Diluted) | 72.22M | 71.94M | 73.34M | 73.48M | 75.66M |
Alto Ingredients, Inc.
NASDAQ:ALTO
Intrinsic Alpha fair value
Locked
Current Price
$3.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.